Abstract
BackgroundAcute aortic dissection (AAD) is a fatal disease demanding prompt diagnosis and proper treatment. There is a lack of serum markers that can effectively assist diagnosis and predict prognosis of AAD patients.MethodsNinety-six AAD patients were enrolled in this study, and 249 patients with chest pain due to acute myocardial infarction, pulmonary embolism, intramural hematoma, angina or other causes and 80 healthy controls were included as control group and healthy control group. Demographics, biochemical and hematological data and risk factors were recorded as baseline characteristics. The 1-year follow-up data were collected and analyzed. The diagnostic performance and ability to predict disease severity and prognosis of NET components in serum and aortic tissue were evaluated.ResultsCirculating NET markers, citH3 (citrullination of histone 3), cell-free DNA (cfDNA) and nucleosomes, had good diagnostic value for AAD, with superior diagnostic performance to D-dimer in discriminating patients with chest pain due to other reasons in the emergency department. Circulating NET marker levels (i.e., citH3, cfDNA and nucleosomes) of AAD patients were significantly higher than that of control group and healthy control group. In addition, circulating NET markers levels were closely associated with the disease severity, in-hospital death and 1-year survival of AAD patients. Systolic blood pressure < 90 mmHg and serum citH3 levels were identified as independent risk factors for 1-year survival of AAD patients. Excessive NET components (i.e., neutrophil elastase and citH3) in the aortic tissue of AAD patient were significantly higher than that of healthy donor aortic tissue. The expression levels of granules and nuclear NET components were significantly higher in aortic tissue from AAD patients than controls.ConclusionsCirculating NET markers, citH3, cfDNA and nucleosomes, have significant diagnostic value and predictive value of disease severity and prognosis of AAD patients. The NETs components may constitute a useful diagnostic and prognostic marker in AAD patients.
Highlights
Acute aortic dissection (AAD) is a fatal aortic disease with high mortality and morbidity that demands prompt diagnosis and proper treatment [1]
We evaluated three different markers of neutrophil extracellular traps (NETs) [i.e., cell-free DNA (cfDNA), nucleosomes and citrullination of histone 3 (citH3)]. citH3 is currently considered to be the most specific marker, as H3 citrullination is required for chromatin decondensation in neutrophils
We examined whether NET markers were independently associated with the 1-year survival of AAD patients
Summary
Acute aortic dissection (AAD) is a fatal aortic disease with high mortality and morbidity that demands prompt diagnosis and proper treatment [1]. There is still a lack of effective markers to accurately predict the inhospital and long-term outcomes of patients with AAD after surgical repair. In patients with AAD receiving surgical repair, the neutrophil to lymphocyte ratio may be used to predict worse outcomes and hospital mortality [6]. Neutrophils play critical roles through the release of neutrophil extracellular traps (NETs), which are extracellular neutrophil-derived weblike structures that constitute a DNA backbone containing histones and neutrophil granule proteins. Acute aortic dissection (AAD) is a fatal disease demanding prompt diagnosis and proper treatment. There is a lack of serum markers that can effectively assist diagnosis and predict prognosis of AAD patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.